Taking out the JuNK to treat alpha(1)-antitrypsin deficiency

摘要

New work has provided insight into the molecular pathways that underlie the liver disease that is associated with alpha(1)-antitrypsin deficiency, and has identified a novel approach to cell-based therapy.